These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 27986441)
1. Silent genetic alterations identified by targeted next-generation sequencing in pheochromocytoma/paraganglioma: A clinicopathological correlations. Pillai S; Gopalan V; Lo CY; Liew V; Smith RA; Lam AK Exp Mol Pathol; 2017 Feb; 102(1):41-46. PubMed ID: 27986441 [TBL] [Abstract][Full Text] [Related]
2. Rare germline mutations identified by targeted next-generation sequencing of susceptibility genes in pheochromocytoma and paraganglioma. Welander J; Andreasson A; Juhlin CC; Wiseman RW; Bäckdahl M; Höög A; Larsson C; Gimm O; Söderkvist P J Clin Endocrinol Metab; 2014 Jul; 99(7):E1352-60. PubMed ID: 24694336 [TBL] [Abstract][Full Text] [Related]
3. Genetic and Clinical Profiles of Pheochromocytoma and Paraganglioma: A Single Center Study. Ma X; Li M; Tong A; Wang F; Cui Y; Zhang X; Zhang Y; Chen S; Li Y Front Endocrinol (Lausanne); 2020; 11():574662. PubMed ID: 33362715 [TBL] [Abstract][Full Text] [Related]
5. Novel SDHB and TMEM127 Mutations in Patients with Pheochromocytoma/Paraganglioma Syndrome. Patócs A; Lendvai NK; Butz H; Liko I; Sapi Z; Szucs N; Toth G; Grolmusz VK; Igaz P; Toth M; Rácz K Pathol Oncol Res; 2016 Oct; 22(4):673-9. PubMed ID: 26960314 [TBL] [Abstract][Full Text] [Related]
6. A comprehensive next generation sequencing-based genetic testing strategy to improve diagnosis of inherited pheochromocytoma and paraganglioma. Rattenberry E; Vialard L; Yeung A; Bair H; McKay K; Jafri M; Canham N; Cole TR; Denes J; Hodgson SV; Irving R; Izatt L; Korbonits M; Kumar AV; Lalloo F; Morrison PJ; Woodward ER; Macdonald F; Wallis Y; Maher ER J Clin Endocrinol Metab; 2013 Jul; 98(7):E1248-56. PubMed ID: 23666964 [TBL] [Abstract][Full Text] [Related]
7. Variant type is associated with disease characteristics in SDHB, SDHC and SDHD-linked phaeochromocytoma-paraganglioma. Bayley JP; Bausch B; Rijken JA; van Hulsteijn LT; Jansen JC; Ascher D; Pires DEV; Hes FJ; Hensen EF; Corssmit EPM; Devilee P; Neumann HPH J Med Genet; 2020 Feb; 57(2):96-103. PubMed ID: 31492822 [TBL] [Abstract][Full Text] [Related]
8. Novel Germline Provenzano A; Chetta M; De Filpo G; Cantini G; La Barbera A; Nesi G; Santi R; Martinelli S; Rapizzi E; Luconi M; Maggi M; Mannelli M; Ercolino T; Canu L Medicina (Kaunas); 2022 Aug; 58(8):. PubMed ID: 36013579 [TBL] [Abstract][Full Text] [Related]
9. An overview of 20 years of genetic studies in pheochromocytoma and paraganglioma. Buffet A; Burnichon N; Favier J; Gimenez-Roqueplo AP Best Pract Res Clin Endocrinol Metab; 2020 Mar; 34(2):101416. PubMed ID: 32295730 [TBL] [Abstract][Full Text] [Related]
10. Integrative genetic characterization and phenotype correlations in pheochromocytoma and paraganglioma tumours. Crona J; Nordling M; Maharjan R; Granberg D; Stålberg P; Hellman P; Björklund P PLoS One; 2014; 9(1):e86756. PubMed ID: 24466223 [TBL] [Abstract][Full Text] [Related]
11. Germline mutations and genotype-phenotype correlations in patients with apparently sporadic pheochromocytoma/paraganglioma in Korea. Kim JH; Seong MW; Lee KE; Choi HJ; Ku EJ; Bae JH; Park SS; Choi SH; Kim SW; Shin C; Kim SY Clin Genet; 2014 Nov; 86(5):482-6. PubMed ID: 24134185 [TBL] [Abstract][Full Text] [Related]
12. Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility. Astuti D; Hart-Holden N; Latif F; Lalloo F; Black GC; Lim C; Moran A; Grossman AB; Hodgson SV; Freemont A; Ramsden R; Eng C; Evans DG; Maher ER Clin Endocrinol (Oxf); 2003 Dec; 59(6):728-33. PubMed ID: 14974914 [TBL] [Abstract][Full Text] [Related]
13. Germline mutations and genotype-phenotype correlation in Asian Indian patients with pheochromocytoma and paraganglioma. Pandit R; Khadilkar K; Sarathi V; Kasaliwal R; Goroshi M; Khare S; Nair S; Raghavan V; Dalvi A; Hira P; Fernandes G; Sathe P; Rojekar A; Malhotra G; Bakshi G; Prakash G; Bhansali A; Walia R; Kamalanathan S; Sahoo J; Desai A; Bhagwat N; Mappa P; Rajput R; Chandrashekhar SR; Shivane V; Menon P; Lila A; Bandgar T; Shah N Eur J Endocrinol; 2016 Oct; 175(4):311-23. PubMed ID: 27539324 [TBL] [Abstract][Full Text] [Related]
14. Germline Mutations and Phenotypic Associations in Korean Patients With Pheochromocytoma and Paraganglioma: A Multicenter Study and Literature Review. Jo KH; Lee J; Yoo J; Kim HS; Kim ES; Han JH; Jang YS; Yun JS; Son JW; Yoo SJ; Lee SH; Lim DJ; Kwon HS; Lee S; Moon S; Kim M Ann Lab Med; 2024 Nov; 44(6):591-597. PubMed ID: 39069753 [TBL] [Abstract][Full Text] [Related]
15. Testing new susceptibility genes in the cohort of apparently sporadic phaeochromocytoma/paraganglioma patients with clinical characteristics of hereditary syndromes. Pęczkowska M; Kowalska A; Sygut J; Waligórski D; Malinoc A; Janaszek-Sitkowska H; Prejbisz A; Januszewicz A; Neumann HP Clin Endocrinol (Oxf); 2013 Dec; 79(6):817-23. PubMed ID: 23551045 [TBL] [Abstract][Full Text] [Related]
16. Genetic Analysis and Clinical Characteristics of Hereditary Pheochromocytoma and Paraganglioma Syndrome in Korean Population. Choi H; Kim KJ; Hong N; Shin S; Choi JR; Kang SW; Lee ST; Rhee Y Endocrinol Metab (Seoul); 2020 Dec; 35(4):858-872. PubMed ID: 33397040 [TBL] [Abstract][Full Text] [Related]
17. Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma. Bayley JP; van Minderhout I; Weiss MM; Jansen JC; Oomen PH; Menko FH; Pasini B; Ferrando B; Wong N; Alpert LC; Williams R; Blair E; Devilee P; Taschner PE BMC Med Genet; 2006 Jan; 7():1. PubMed ID: 16405730 [TBL] [Abstract][Full Text] [Related]
20. Genetic predisposition to pheochromocytoma and paraganglioma: 21 years of experience in the field. Cardot-Bauters C; Vantyghem MC; Do Cao C; Desailloud R; Joubert M; Coppin L; Odou MF; Pigny P Ann Endocrinol (Paris); 2024 Jul; 85(4):276-283. PubMed ID: 38815921 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]